ECNP launches course on psychedelic research, featuring PAREA Board Chair Prof. David Nutt
One of PAREA's Founding Members, the European College of Neuropsychopharmacology (ECNP), is launching a free 12-lecture course on psychedelic research: "Psychedelic Research: Science, Therapy and Future Directions in Mental Health," covering the neurobiological mechanisms, clinical protocols, safety considerations, and future directions of psychedelics in mental health care. It convenes many of the leading European researchers working in this area, including PAREA Board Chair Professor David Nutt from Imperial College London.
This represents precisely the kind of progress the field requires: mainstream scientific and clinical institutions helping to build the knowledge base around what these therapies are, how they work, their associated risks, and the questions that still need to be addressed.Enrol for free before 14 September on the ECNP Knowledge Hub.
Learning objectives
Recall key concepts, terminology, and substances in psychedelic research, including mechanisms of action and legal–ethical frameworks.
Explain how psychedelics affect brain function and behaviour, integrating evidence from preclinical studies, neuroimaging, and clinical trials.
Apply methodological and ethical principles to interpret psychedelic research findings and evaluate their relevance for clinical trial design and mental health practice.
